Assessing genital sensitivity and sexual function after gender-affirming surgery
Official title: Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery
Run by University Hospital, Ghent · NCT04993469 · Data updated 2026-11-12
This study is trying to see how gender-affirming surgery affects genital sensitivity and sexual function in transgender individuals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 110 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent, East-Flanders) |
| Status | Recruiting |
| Started | May 27, 2021 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | December 22, 2023 |
| Trial ID | NCT04993469 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include transgender individuals aged 18 and older with diagnosed gender dysphoria who are seeking genital gender-affirming surgery.
✕Probably not a fit
Patients who are cisgender or those who are unfit for surgery will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the impact of genital gender-affirming surgery on genital sensitivity and sexual functioning in individuals with gender dysphoria. It involves transgender males and females who wish to undergo surgeries such as phalloplasty, metoidioplasty, vaginoplasty, or vulvoplasty. Participants will undergo Semmes-Weinstein monofilament testing and complete questionnaires to assess their outcomes post-surgery. The goal is to better understand the relationship between surgical techniques and sexual function outcomes.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into improving sexual function and satisfaction for transgender individuals post-surgery.
How similar studies have gone: While there have been studies on urological outcomes, this specific focus on genital sensitivity and sexual function post-surgery is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations * Patient age ≥ 18 years * Transgender male, female of gender non-conforming patient with diagnosed gender dysphoria and the specific wish to undergo genital gender affirming surgery * Fit for operation, based on the surgeon's expert opinion * Patient is able and willing to attend the follow-up consultations Exclusion Criteria: * Absence of signed written informed consent and thus a patient unwilling to participate. * Patient age \< 18 years * Cisgender patients * Patients unfit for operation * Patient declares that it will be impossible for him to attend the follow-up consultations
Where it's running
-
University Hospital Ghent
Ghent, East-Flanders, Belgium Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain health changes after gender-affirming hormone therapy in transgender adults
This study tests how starting gender-affirming hormone therapy may affect brain blood flow, structure, connectivity, and cognitive function in transgender adults.
-
Topical estrogen cream to improve recovery for transgender men after hysterectomy
This study tests if using a special estrogen cream after surgery can help transgender men recover better and feel more comfortable after a hysterectomy.
-
Evaluating voice outcomes after gender-affirming voice surgeries
This study is testing how different gender-affirming voice surgeries affect voice quality and patient satisfaction over time.
-
Evaluating hormonal treatment for adolescents with gender dysphoria
This study tests if giving cross-sex hormones to teens with gender dysphoria who have started their social transition helps them feel better and function well compared to those who don’t receive the hormones.
-
Effects of gender-affirming hormone therapy on heart and metabolic health
This study is trying to see how gender-affirming hormone therapy affects heart health, metabolism, and mental well-being in transgender people over several years.
-
Effects of hormone treatment on heart and liver health in transgender individuals
This study tests how hormone treatment affects heart and liver health in transgender individuals by looking at changes before and after six months of therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.